dr. ramalingam on side effects associated with immunotherapy in lung cancer
Published 9 years ago • 2K plays • Length 3:13Download video MP4
Download video MP3
Similar videos
-
3:05
suresh ramalingam discusses side effects associated with immunotherapy in lung cancer
-
2:15
dr. ramalingam on pembrolizumab and chemotherapy in nsclc
-
1:21
dr. suresh s. ramalingam on optimizing immunotherapies in lung cancer
-
2:32
what side effects can be associated with immunotherapy for lung cancer?
-
1:40
suresh ramalingam on toxicities associated with immunotherapy in different disease types
-
1:19
dr. ramalingam on emerging combination regimens in nsclc
-
0:59
dr. ramalingam on next steps with nivolumab/ipilimumab in nsclc
-
18:01
living with lung cancer podcast: immunotherapy side effects
-
0:56
dr. ramalingam on treatment parameters for osimertinib in lung cancer
-
2:00
marianne davies on managing immunotherapy side effects in lung cancer
-
2:47
dr ramalingam on updates in lung cancer following the 2024 asco annual meeting
-
1:59
dr. brahmer on side effects of immunotherapy for lung cancer
-
1:10
dr. suresh ramalingam on immune checkpoint inhibitors in nsclc treatment
-
0:57
dr. decker discusses aes associated with radiation in lung cancer
-
1:34
dr. ramalingam on new data for egfr inhibitors for lung cancer
-
1:01
dr. heymach on nivolumab for lung cancer
-
2:34
dr. ramalingam on flaura findings in egfr-mutant nsclc
-
1:29
dr. brahmer on managing immune-related aes in lung cancer
-
4:15
the toxicities associated with immunotherapy in lung cancer patients